CHINA PHARMA HOLDINGS, INC. Convertible Notes Payable, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Convertible Notes Payable, Current of $315.43 thousand as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleNotesPayableCurrent · last filed 2025-03-31
- 2024-09-30: Convertible Notes Payable, Current $315.43K.
- 2024-06-30: Convertible Notes Payable, Current $410.42K.
- 2023-12-31: Convertible Notes Payable, Current $940.00K.
- 2023-09-30: Convertible Notes Payable, Current $1.74M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2024-09-30 | $315.43K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $410.42K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $940.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.74M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.35M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.15M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.80M 10-K · filed 2024-04-01 |
| 2022-09-30 | $4.55M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |